ReviewFrontiers in pharmacology2025

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.

Tian-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.